Vanguard Capital Management
CLMT icon

Vanguard Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Vanguard Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124M Buy
3,453,911
+18,517
+0.5% +$622K ﹤0.01% 1437
2026
Q1 		$123M Buy
+3,435,394
New +$88.9M ﹤0.01% 1359

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management's CLMT Position: Q2 2026 in Review

Vanguard Capital Management increased its Calumet Specialty Products (CLMT) stake by 0.54% in Q2 2026, buying an estimated $622K and bringing the position to 3,453,911 shares worth $124M. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Vanguard Capital Management first reported a position in CLMT in Q1 2026 and has held it in 2 quarters since. 187 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Vanguard Capital Management held 3,453,911 shares of Calumet Specialty Products worth $124M as of Q2 2026.
  • Vanguard Capital Management bought 18,517 Calumet Specialty Products shares in Q2 2026, an estimated $622K.
  • Calumet Specialty Products made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1437 holding.
  • Vanguard Capital Management first reported a position in Calumet Specialty Products in Q1 2026 and has held it in 2 quarters since.
  • 187 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.